HomeCompareERPRF vs MRK

ERPRF vs MRK: Dividend Comparison 2026

ERPRF yields 9.42% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $20.4K in total portfolio value· pulled ahead in Year 7
10 years
ERPRF
ERPRF
● Live price
9.42%
Share price
$5.20
Annual div
$0.49
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.3K
Annual income
$1,705.61
Full ERPRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — ERPRF vs MRK

📍 MRK pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodERPRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ERPRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ERPRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERPRF
Annual income on $10K today (after 15% tax)
$800.96/yr
After 10yr DRIP, annual income (after tax)
$1,449.77/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $7,146.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERPRF + MRK for your $10,000?

ERPRF: 50%MRK: 50%
100% MRK50/50100% ERPRF
Portfolio after 10yr
$47.5K
Annual income
$5,909.69/yr
Blended yield
12.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ERPRF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERPRF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricERPRFMRK
Forward yield9.42%2.81%
Annual dividend / share$0.49$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$37.3K$57.7K
Annual income after 10y$1,705.61$10,113.78
Total dividends collected$13.2K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ERPRF vs MRK ($10,000, DRIP)

YearERPRF PortfolioERPRF Income/yrMRK PortfolioMRK Income/yrGap
1$11,642$942.31$11,213$373.04+$429.00ERPRF
2$13,483$1,025.29$12,667$512.06+$816.00ERPRF
3$15,536$1,109.68$14,439$708.14+$1.1KERPRF
4$17,819$1,195.04$16,640$988.16+$1.2KERPRF
5$20,347$1,280.95$19,432$1,394.07+$915.00ERPRF
6$23,138$1,367.01$23,057$1,992.90+$81.00ERPRF
7← crossover$26,211$1,452.84$27,889$2,894.79$1.7KMRK
8$29,583$1,538.10$34,518$4,286.29$4.9KMRK
9$33,277$1,622.45$43,912$6,494.35$10.6KMRK
10$37,312$1,705.61$57,714$10,113.78$20.4KMRK

ERPRF vs MRK: Complete Analysis 2026

ERPRFStock

European Reliance General Insurance Company S.A., together with its subsidiaries, provides various insurance products and services to individuals and businesses in Greece. The company offers income protection, medical expenses, family, child, motor, home, health, and quality life insurances, as well as pension programs. It also provides business insurance programs, such as building coverage, group, cargo, and third party liability insurance programs; and financial loss programs that cover loss of income, loss of profits, loss of wages, and operating expenses. In addition, the company offers facility management services; mutual fund management services, including portfolio management, corporate finance, and venture capital; investment services; and housekeeping services. Further, it acts as an insurance broker; and produces electricity through photovoltaic power stations. The company offers products and services through a network of sales persons, as well as through online. European Reliance General Insurance Company S.A. was founded in 1977 and is headquartered in Chalandri, Greece.

Full ERPRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ERPRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERPRF vs SCHDERPRF vs JEPIERPRF vs OERPRF vs KOERPRF vs MAINERPRF vs JNJERPRF vs ABBVERPRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.